Biotech Growth (UK) Analysis
| BIOG Stock | 808.00 6.00 0.75% |
The Biotech Growth is fairly valued with Real Value of 809.25 and Hype Value of 810.5. The main objective of Biotech Growth stock analysis is to determine its intrinsic value, which is an estimate of what The Biotech Growth is worth, separate from its market price. There are two main types of Biotech Growth's stock analysis: fundamental analysis and technical analysis. Fundamental analysis focuses on the financial and economic factors that affect Biotech Growth's performance, such as revenue growth, earnings, and financial stability. Technical analysis, on the other hand, focuses on the price and volume data of Biotech Growth's stock to identify patterns and trends that may indicate its future price movements.
The Biotech Growth stock is traded in UK on London Exchange, with the market opening at 08:00:00 and closing at 16:30:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in UK. Biotech Growth is usually not traded on Good Friday, Easter Monday, May Day Bank Holiday, Spring Bank Holiday ( 2025 ), Summer Bank Holiday, Christmas Day, Boxing Day, New Year 's Day. Biotech Stock trading window is adjusted to Europe/London timezone.
Biotech |
Biotech Stock Analysis Notes
About 36.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.93. Some equities with similar Price to Book (P/B) outperform the market in the long run. Biotech Growth last dividend was issued on the 4th of July 2001. For more info on The Biotech Growth please contact the company at 212-739-6400 or go to https://www.biotechgt.com/index.php/biog/home/over.Biotech Growth Investment Alerts
| Net Loss for the year was (82.52 M) with profit before overhead, payroll, taxes, and interest of 101.17 M. | |
| Biotech Growth generates negative cash flow from operations | |
| Latest headline from news.google.com: The Biotech Growth Trust Shares Up 2.1 percent - Time to Buy - MarketBeat |
Biotech Growth Thematic Classifications
In addition to having Biotech Growth stock in your portfolios, you can add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your favorite investment opportunity, you can then obtain an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility. If you are a result-oriented investor, you can benefit from optimizing one of our existing themes to build an efficient portfolio against your specific investing outlook.
 | ITInformation technology and IT services |
Biotech Market Capitalization
The company currently falls under 'Small-Cap' category with a current market capitalization of 204.98 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Biotech Growth's market, we take the total number of its shares issued and multiply it by Biotech Growth's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Biotech Profitablity
Biotech Growth's profitability indicators refer to fundamental financial ratios that showcase Biotech Growth's ability to generate income relative to its revenue or operating costs. If, let's say, Biotech Growth is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Biotech Growth's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Biotech Growth's profitability requires more research than a typical breakdown of Biotech Growth's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
The company has Profit Margin (PM) of 0.95 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.8 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.8. Management Efficiency
Biotech Growth has return on total asset (ROA) of 0.1698 % which means that it generated a profit of $0.1698 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.2979 %, meaning that it generated $0.2979 on every $100 dollars invested by stockholders. Biotech Growth's management efficiency ratios could be used to measure how well Biotech Growth manages its routine affairs as well as how well it operates its assets and liabilities. At this time, Biotech Growth's Total Assets are comparatively stable compared to the past year. Non Current Assets Total is likely to gain to about 333.7 M in 2025, whereas Other Current Assets are likely to drop slightly above 16.1 K in 2025.Leadership effectiveness at The Biotech Growth is a strong indicator of its financial stability. We analyze various metrics to provide insights into the stock's investment viability.
Technical Drivers
As of the 21st of July, Biotech Growth shows the Semi Deviation of 1.6, risk adjusted performance of 0.1613, and Mean Deviation of 1.23. Biotech Growth technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices. Please confirm Biotech Growth mean deviation, downside deviation, standard deviation, as well as the relationship between the semi deviation and coefficient of variation to decide if Biotech Growth is priced correctly, providing market reflects its regular price of 808.0 per share.Biotech Growth Price Movement Analysis
The output start index for this execution was twenty-nine with a total number of output elements of thirty-two. The Simple Moving Average indicator is calculated by adding the closing price of Biotech Growth for a given number of time periods and then dividing this total by the number of time periods. It is used to smooth out Biotech Growth short-term fluctuations and highlight longer-term trends or cycles.
Biotech Growth Outstanding Bonds
Biotech Growth issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Biotech Growth uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Biotech bonds can be classified according to their maturity, which is the date when The Biotech Growth has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| MPLX LP 4125 Corp BondUS55336VAK61 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| Morgan Stanley 3971 Corp BondUS61744YAL20 | View | |
| Valero Energy Partners Corp BondUS91914JAA07 | View |
Biotech Growth Predictive Daily Indicators
Biotech Growth intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Biotech Growth stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Biotech Growth Forecast Models
Biotech Growth's time-series forecasting models are one of many Biotech Growth's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Biotech Growth's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About Biotech Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how Biotech Growth prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Biotech shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Biotech Growth. By using and applying Biotech Stock analysis, traders can create a robust methodology for identifying Biotech entry and exit points for their positions.
Biotech Growth is entity of United Kingdom. It is traded as Stock on LSE exchange.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our stock analysis tools, you can find out how much better you can do when adding Biotech Growth to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Instant Ratings Now
Instant RatingsDetermine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Additional Tools for Biotech Stock Analysis
When running Biotech Growth's price analysis, check to measure Biotech Growth's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Biotech Growth is operating at the current time. Most of Biotech Growth's value examination focuses on studying past and present price action to predict the probability of Biotech Growth's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Biotech Growth's price. Additionally, you may evaluate how the addition of Biotech Growth to your portfolios can decrease your overall portfolio volatility.